3-(4-ethylphenyl)prop-2-ynoic acid, 95.0%, 250mg

(R)-tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate hydrochloride, 95.0%, 250mg

1-Ethyl-2-fluoro-4-methoxy-5-nitrobenzene, 98.0%, 1g

4-(Benzyloxy)-5-bromo-2-chloropyrimidine, 95.0%, 25g

Methyl 5-carbamoyl-2-methoxybenzoate, 95.0%, 1g

Acide oxalique dihydraté, min 99%, cristallisé, 10 kg, emballage plastique.

Methyl 6-chloro-5-methylnicotinate, 95%, 5g

(S)-2-Amino-2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)ethan-1-ol, 95%, 250mg

Pastilles de tantale 99,9+% 6 x 6 mm 25 g

(1R,2S,5S)-6,6-Dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 97%, 250mg

(1S,2S)-N1,N1,N2,N2-Tetramethylcyclohexane-1,2-diamine, 97%, 10g

4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-carbonitrile, 95.0%, 25g

Hexadecylpyridinium Bromide>96.0%(HPLC)(T)500g